Alloy Therapeutics, Inc.

Empowering scientists with foundational drug discovery platforms and services

Alloy Therapeutics was founded in 2017 by Errik Anderson, one of the founders of Adimab. The company's mission is to empower scientists with foundational drug discovery platforms and services. Their first platform is the GK mouse, which is an immunocompetent transgenic mouse model for antibody discovery. Alloy is developing additional platforms to provide new offerings in the future.